GARDskin approved by OECD
THE FIRST AND ONLY Genomics and Machine-learning based in vitro skin sensitization assay
The GARD® technology: An holistic approach
SenzaGen provides state-of-the-art non-animal tests for assessing a substance’s allergenicity. With excellent predictivity, the tests meet needs in several industries and help companies develop, produce and deliver safer, ethical and more sustainable products.
Press Releases
06 Mar, 2024
News
IR
English
Corporate Information
Other Corporate Information
14 Feb, 2024
News
IR
English
Regulatory
MAR
Report
Interim
Yearend
07 Feb, 2024
News
IR
English
Corporate Information
Presentation
News Posts
Quick Links
Contact
Privacy Policy (En)
Privacy Policy (Sv)
General Terms and Conditions
© SenzaGen 2026





